![Randal A. Hassler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Randal A. Hassler
Plus aucun poste en cours
Historique de carrière de Randal A. Hassler
Anciens postes connus de Randal A. Hassler
Sociétés | Poste | Début | Fin |
---|---|---|---|
Seattle Biomedical Research Institute
![]() Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Directeur des opérations | 01/01/2008 | 01/01/2014 |
Directeur Financier/CFO | 22/11/2010 | 01/01/2014 | |
AMGEN INC. | Corporate Officer/Principal | 01/01/1995 | 01/01/2007 |
ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2014 | - |
Formation de Randal A. Hassler
Indiana University | Undergraduate Degree |
Colorado State University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Director of Finance/CFO | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
AMGEN INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Seattle Biomedical Research Institute
![]() Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Commercial Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
![]() Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
- Bourse
- Insiders
- Randal A. Hassler
- Expérience